EXICURE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
EXICURE, INC. (XCUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 84 shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-11-14
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was -332.00 shares, a 100.21% decline year-over-year.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 416.00 shares, a 98.59% decline year-over-year.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 154.79K shares, a 3146.46% increase year-over-year.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 351.62K shares, a 869.13% increase from fiscal 2018.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 36.28K shares, a 124.87% increase from fiscal 2017.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 16.14K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2024-09-30 | -332.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -332.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 84.00 shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 416.00 shares 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 416.00 shares 10-Q · filed 2024-06-17 | |||
| 2023-09-30 | 154.79K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | 191.29K shares derived: sum of 2 quarters · filed 2024-06-06 | 220.72K shares 10-Q · filed 2024-05-16 | |
| 2023-06-30 | 36.50K shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | 65.93K shares 10-Q/A · filed 2024-06-06 | ||
| 2023-03-31 | 29.43K shares 10-Q/A · filed 2024-06-06 | |||
| 2022-09-30 | 4.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -2.73M shares derived: sum of 2 quarters · filed 2022-11-14 | 250.83K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -2.73M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 246.06K shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 2.98M shares 10-Q · filed 2022-05-16 | |||
| 2021-09-30 | 156.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | 197.68K shares derived: sum of 2 quarters · filed 2021-11-19 | 252.68K shares 10-Q · filed 2021-11-19 | |
| 2021-06-30 | 40.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 95.70K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 55.00K shares 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | 12.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 119.73K shares derived: sum of 2 quarters · filed 2020-03-10 | 288.19K shares derived: sum of 3 quarters · filed 2020-03-10 | 351.62K shares 10-K · filed 2020-03-10 |
| 2019-09-30 | 107.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 275.96K shares derived: sum of 2 quarters · filed 2019-11-07 | 339.39K shares 10-Q · filed 2019-11-07 | 339.39K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 168.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 231.89K shares 10-Q · filed 2019-08-08 | 231.89K shares derived: sum of 3 quarters · filed 2019-09-23 | 260.57K shares derived: sum of 4 quarters · filed 2019-09-23 |
| 2019-03-31 | 63.43K shares 10-Q · filed 2019-05-08 | 63.43K shares derived: sum of 2 quarters · filed 2019-09-23 | 92.11K shares derived: sum of 3 quarters · filed 2019-09-23 | 97.07K shares derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | 28.68K shares derived: sum of 2 quarters · filed 2019-09-23 | 33.64K shares derived: sum of 3 quarters · filed 2019-09-23 | 36.28K shares 10-K/A · filed 2019-09-23 |
| 2018-09-30 | 28.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 33.64K shares derived: sum of 2 quarters · filed 2018-11-06 | 36.28K shares 10-Q · filed 2018-11-06 | 42.02K shares derived: sum of 4 quarters · filed 2018-11-06 |
| 2018-06-30 | 4.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | 7.60K shares 10-Q · filed 2018-08-06 | 13.34K shares derived: sum of 3 quarters · filed 2018-08-06 | |
| 2018-03-31 | 2.64K shares 10-Q · filed 2018-05-15 | 8.38K shares derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2017-12-31 | 5.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 16.14K shares 10-K · filed 2018-03-09 | ||
| 2017-09-30 | 10.40K shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |